Skip to main content
. 2022 Jun 27;66(4):506–511. doi: 10.20945/2359-3997000000495

Table 2. Individual tumor volume outcome of the 12 patients treated primarily with cabergoline (CBG) (*last available measurement while on CBG).

Patient Age Sex Cavernous Sinus invasion Tumor volume mm3 Status
Pre-CBG On CBG*
1 50 M No 10195 13659 Growth
2 71 M No 2028 2028 Stable
3 46 F No 678 778 Stable
4 76 F No 1949 1714 Stable
5 80 F Yes 16933 16900 Stable
6 44 F No 1291 2198 Growth
7 54 M Yes 9538 523 Reduction
8 64 M No 653 100 Reduction
9 73 M Yes 5610 6939 Growth
10 66 F Yes 2395 2763 Stable
11 41 M Yes 10257 8164 Reduction
12 75 F Yes 691 523 Reduction